V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20214811 | 20130072 | 1.81 | 65 | Palliative (P) | 2020-03-06 | 2020-03-07 | Sorafenib | 02 | N | SORAFENIB | 101460566 |
| 20214816 | 20130073 | 1.62 | 42.5 | Palliative (P) | 2018-02-25 | 2018-04-04 | Trial Unspecified | 2 | N | TRIAL | 100497187 |
| 20214819 | 20130074 | 1.57 | 70 | Palliative (P) | 2019-10-26 | 2019-11-01 | EOX | 01 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 100479952 |
| 20214820 | 20130075 | 1.74 | 89 | Palliative (P) | 2018-09-26 | 2018-10-08 | EOX | 02 | N | OXALIPLATIN + RALTITREXED | 101487856 |
| 20214821 | 20130076 | 1.63 | 56.4 | Adjuvant (A) | 2020-01-25 | 2021-01-11 | Cetuximab + FLUOROURACIL + OXALIPLATIN | 02 | Y | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 100808877 |
| 20214822 | 20130077 | 1.58 | 62.9 | Palliative (P) | 2019-06-23 | 2019-11-04 | Trial Unspecified | 01 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 101704048 |
| 20214824 | 20130078 | 1.57 | 61.6 | null | 2018-03-20 | 2018-03-21 | Capecitabine 42days + RT | N | null | CAPECITABINE + RT | 101510025 |
| 20214825 | 20130079 | 1.76 | 66.8 | Palliative (P) | 2021-01-14 | 2021-02-03 | Cetuximab + Oxaliplatin + MdG Maint | 2 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 100335688 |
| 20214826 | 20130080 | 1.79 | 54.6 | Palliative (P) | 2018-04-15 | 2018-04-26 | CAPECITABINE + RT | 02 | N | CAPECITABINE + RT | 100918669 |
| 20214828 | 20130081 | 1.58 | 70.6 | Palliative (P) | 2020-11-08 | 2020-11-09 | IRINOTECAN + MDG + PANITUMUMAB | 02 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 100269835 |
| 20214830 | 20130082 | 1.76 | 92 | 03 | 2019-09-08 | 2019-09-11 | Trial Unspecified | 1 | null | TRIAL | 100315596 |
| 20214831 | 20130083 | 1.64 | 73.4 | Palliative (P) | 2018-05-20 | 2018-06-10 | Trial Unspecified | N | null | TRIAL | 100607024 |
| 20214833 | 20130084 | 1.9 | 79.6 | Palliative (P) | 2017-09-29 | 2017-09-29 | CAPECITABINE + RT | N | N | CAPECITABINE + RT | 100260972 |
| 20214834 | 20130085 | 1.85 | 71.6 | Palliative (P) | 2020-03-21 | 2020-03-31 | EOX | N | N | CETUXIMAB + IRINOTECAN + MDG | 100900742 |
| 20214835 | 20130086 | 1.72 | 54.6 | Palliative (P) | 2018-06-07 | 2018-06-07 | CAPECITABINE + RT | N | N | CAPECITABINE + RT | 101479784 |
| 20214836 | 20130087 | 1.81 | 71 | Palliative (P) | 2019-05-24 | 2019-11-19 | Capecitabine 5days + RT | 02 | N | CAPECITABINE + RT | 101491028 |
| 20214839 | 20130088 | 1.62 | null | Palliative (P) | 2017-03-05 | 2017-03-15 | Trial Unspecified | 02 | N | TRIAL | 100794594 |
| 20214840 | 20130089 | 1.72 | 60 | Adjuvant (A) | 2017-04-01 | 2017-04-01 | CAPECITABINE + RT | 02 | N | CAPECITABINE + RT | 100191706 |
| 20214842 | 20130090 | 0 | 61 | Curative (C) | 2018-10-12 | 2018-10-26 | Oxaliplatin + Raltitrexed | 02 | N | OXALIPLATIN + RALTITREXED | 101684077 |
| 20214843 | 20130091 | 1.69 | 62.9 | null | 2014-06-04 | 2014-06-21 | Cetuximab + FOLFIRI cycle 2 onwards | N | y | EOX | 100155282 |
| 20214844 | 20130092 | 1.82 | 68 | Neo-adjuvant (N) | 2018-11-11 | 2018-11-27 | Sorafenib | 02 | N | SORAFENIB | 101295846 |
| 20214845 | 20130093 | 1.75 | 69 | Neo-adjuvant (N) | 2020-04-18 | 2020-05-03 | EOX | 02 | N | CAPECITABINE + RT | 101861375 |
| 20214846 | 20130094 | 1.69 | 61 | Disease modification (D) | 2020-05-23 | 2020-06-28 | Sorafenib | 99 | null | SORAFENIB | 100706068 |
| 20214847 | 20130095 | 1.74 | 82.2 | Palliative (P) | 2018-12-12 | 2019-01-18 | EOX | 02 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 101719580 |
| 20214848 | 20130096 | 1.72 | 55.6 | null | 2020-02-05 | 2020-02-19 | EOX | 02 | null | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 100413053 |
| 20214850 | 20130097 | 1.75 | null | Palliative (P) | 2016-08-05 | 2016-09-02 | GO2 TRIAL | 2 | N | TRIAL | 101807029 |
| 20214851 | 20130098 | null | 56.4 | Palliative (P) | 2017-11-08 | 2019-01-06 | EOX | N | N | CETUXIMAB + IRINOTECAN + MDG | 100459835 |
| 20214852 | 20130099 | 1.76 | 102.9 | Palliative (P) | 2016-11-14 | 2016-11-21 | Cetuximab + Oxaliplatin + MdG Maint | 02 | null | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 101194972 |
| 20214853 | 20130100 | 1.85 | null | Palliative (P) | 2018-11-14 | 2018-11-26 | EOX | 02 | N | CAPECITABINE + RT | 101144697 |
| 20214856 | 20130101 | 1.71 | 71.2 | null | 2017-05-04 | 2017-05-09 | Oxaliplatin + Raltitrexed | 2 | N | OXALIPLATIN + RALTITREXED | 101252800 |
| 20214857 | 20130102 | 0 | 72.4 | Palliative (P) | 2017-08-19 | 2017-08-19 | EOX | 2 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 101468789 |
| 20214859 | 20130103 | 1.68 | 60.55 | Palliative (P) | 2021-01-06 | 2021-01-08 | EOX | 02 | N | EOX | 100718005 |
| 20214862 | 20130104 | null | 88.1 | Palliative (P) | 2018-02-03 | 2018-06-16 | EOX | N | N | EOX | 100004614 |
| 20214866 | 20130105 | 1.66 | 87.35 | Palliative (P) | 2017-12-22 | 2017-12-22 | Cetuximab + FOLFIRI cycle 2 onwards | N | null | CETUXIMAB + IRINOTECAN + MDG | 100083458 |
| 20214868 | 20130106 | 1.78 | 109.6 | Palliative (P) | 2018-07-15 | 2018-07-29 | EOX | Y | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 101141735 |
| 20214869 | 20130107 | 1.65 | 52 | Curative (C) | 2018-08-27 | 2018-10-01 | EOX | N | Y | CETUXIMAB + IRINOTECAN + MDG | 101475991 |
| 20214870 | 20130108 | 1.69 | 87.35 | Adjuvant (A) | 2017-10-12 | 2017-11-12 | Cetuximab + FLUOROURACIL + OXALIPLATIN | 01 | Y | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 100940441 |
| 20214873 | 20130109 | 1.63 | 0 | Palliative (P) | 2019-03-04 | 2019-03-28 | Trial Unspecified | Y | N | TRIAL | 101745056 |
| 20214875 | 20130110 | 1.66 | 107.5 | Palliative (P) | 2018-12-11 | 2018-12-11 | CETUXIMAB + IRINOTECAN + MDG | N | N | CETUXIMAB + IRINOTECAN + MDG | 100896304 |
| 20214876 | 20130111 | 1.63 | 87.2 | Palliative (P) | 2017-09-03 | 2017-09-03 | EOX | N | N | EOX | 100019592 |
| 20214877 | 20130112 | 1.72 | 77.2 | Neo-adjuvant (N) | 2019-04-21 | 2019-11-20 | EOX | 2 | Y | SORAFENIB | 100263639 |
| 20214879 | 20130113 | 1.66 | 78.3 | Palliative (P) | 2020-07-21 | 2020-08-18 | Oxaliplatin + Raltitrexed | 1 | null | OXALIPLATIN + RALTITREXED | 101208517 |
| 20214880 | 20130114 | 1.72 | 96.8 | Neo-adjuvant (N) | 2019-07-10 | 2019-07-10 | CETUXIMAB + IRINOTECAN + MDG | N | N | CETUXIMAB + IRINOTECAN + MDG | 100034780 |
| 20214881 | 20130115 | 1.63 | 46.5 | Neo-adjuvant (N) | 2016-12-06 | 2017-02-14 | Cetuximab + Oxaliplatin + MdG Maint | 2 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 100896970 |
| 20214882 | 20130116 | 1.72 | 57 | Neo-adjuvant (N) | 2018-01-26 | 2018-03-10 | CAPECITABINE + RT | N | N | CAPECITABINE + RT | 100490931 |
| 20214887 | 20130117 | 1.57 | 86.2 | Palliative (P) | 2019-03-11 | 2019-03-11 | IRINOTECAN + MDG + PANITUMUMAB | 02 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 100602372 |
| 20214888 | 20130118 | 1.7 | 74 | Palliative (P) | 2014-12-25 | 2014-12-25 | Oxaliplatin + Raltitrexed | N | N | EOX | 100057384 |
| 20214889 | 20130119 | 1.74 | 61.6 | Curative (C) | 2016-12-08 | 2017-01-04 | Cetuximab + Oxaliplatin + MdG Maint | 02 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 101801574 |
| 20214890 | 20130120 | 1.79 | 60.5 | Palliative (P) | 2017-12-17 | 2017-12-17 | Cetuximab + FLUOROURACIL + OXALIPLATIN | 02 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 100088431 |
| 20214891 | 20130121 | 1.78 | 67.6 | null | 2018-12-17 | 2018-12-31 | CAPECITABINE + RT | 02 | null | CAPECITABINE + RT | 101751699 |